Inventor · disambiguated record

Meagan P. O'Brien

Also filed as: O'BRIEN MEAGAN · O'BRIEN MEAGAN P

3 granted patents·4 pending applications·5 citations·filing 2020–2023

59Inventor score

Technology areasC07K

Files withREGENERON PHARMA7

Top patents by PatentIndex Score

7 records

0188US11897945B2Methods of treating allergy using anti-Bet v 1 antibodiesREGENERON PHARMA·Filed 2021·Granted Feb 13, 2024·2 cites·37 claims
0284US11999777B2Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodiesREGENERON PHARMA·Filed 2021·Granted Jun 4, 2024·2 cites·68 claims
0377US11504426B2Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonistREGENERON PHARMA·Filed 2020·Granted Nov 22, 2022·1 cites·28 claims
0470US2024092882A1Method of treating an allergy with allergen-specific monoclonal antibodiesREGENERON PHARMA·Filed 2023·Application pending·0 cites
0562US2023293682A1Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r antagonistREGENERON PHARMA·Filed 2022·Application pending·0 cites
0661US2022064270A1Method of treating an allergy with allergen-specific monoclonal antibodiesREGENERON PHARMA·Filed 2021·Application pending·0 cites
0757US2023416349A1Methods Of Identifying And Evaluating Cat Allergy Gene Signatures In A Subject By Determining A Stratified Score Based On Gene ExpressionREGENERON PHARMA·Filed 2023·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Meagan P. O'Brien files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →